Potential Lung Cancer Vaccine Shows Promise
SHARE with Friend
(SACRAMENTO, Calif.) - Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer.
The study also found that radiation treatments did not significantly impair the immune response. The paper was published on March 10 in the journal Cancer Immunology Research, an American Association for Cancer Research (AACR) publication.
Though tecemotide, also known as Stimuvax, has shown great potential at times, the recent Phase III trial found no overall survival benefit for patients with non-small cell lung cancer (NSCLC). However, further analysis showed one group of patients, who received concurrent chemotherapy and radiation followed by tecemotide, did benefit from the vaccine. As a result, tecemotide's manufacturer, Merck KGaA, is sponsoring additional post-clinical animal and human studies, so far with good results.
"There aren't any good options for patients with inoperable stage III lung cancer following mainline chemotherapies," said UC Davis Professor of Medicine and lead author Michael DeGregorio. "We are looking at tecemotide as a potential maintenance therapy to prolong survival and improve quality of life."
Tecemotide activates an immune response by targeting the protein MUC1, which is often overexpressed in lung, breast, prostate and other cancers. The vaccine stimulates production of interferon gamma and MUC1-targeted killer T-lymphocytes, which seek out and destroy MUC1 cancer cells.
The team, which included investigators from the UC Davis School of Veterinary Medicine and the Department of Radiation Oncology, wanted to know if cisplatin/tecemotide treatments, along with radiation therapy, could boost the immune response and alter lung cancer's trajectory, stabilizing the disease.
The study produced a number of positive results. Tecemotide increased interferon gamma levels and boosted the T-cell response to MUC1-expressing cancer cells. When administered by themselves, both tecemotide and cisplatin reduced the number of lung tumors. However, combining these therapies enhanced their impact, suggesting that tecemotide may increase cisplatin's anticancer activity.
Though radiation therapy did reduce the number of lymphocytes, it did not appear to hamper the immune response. In addition, interferon levels actually increased several hours after radiation treatments.
"Radiation may actually be helpful by exposing targets for the vaccine," said DeGregorio.
While this study revives hope for tecemotide as a potential NSCLC therapy, there are still questions to be answered. Researchers need to further refine these therapies to determine which protocols provide the best survival benefits. In addition, tecemotide can only be effective if it does not exhaust the immune system in the process. Still, the research provides a ray of hope for patients with few options.
"We believe this vaccine could be coupled with standard treatments to create a maintenance therapy," said DeGregorio. "If we can help patients with a life expectancy of 18 to 20 months increase that to 30 months or more, with a high quality of life, that's a big benefit."
Other authors included: Chiao-Jung Kao, Gregory T. Wurz, Arta M. Monjazeb, Daniel P. Vang, Timothy B. Cadman, Stephen M. Griffey, all of UC Davis; and Michael Wolf of Merck.
This study was funded by a grant from Merck KGaA.
Print This Article
Placer County News HeadlinesPlacer County Republican Party To Hold 2014 ConventionLOOMIS - The Placer County Republican Party will hold its endorsement convention on Aug. 23 to select which candidates to support for local offices in Placer County.
Job Fair in Roseville August 22ndRoseville, CA -- Multiple community agencies including Brandman University, The City of Roseville Libraries, Placer, Sacramento and El Dorado Counties, Golden Sierra Job Training, and Sacramento Works
Roseville Crime Report Digest Update (7.23.14)The Roseville Police Department weekly crime report digest update for July 23, 2014.
California Limits Full Contact Football for StudentsGovernor Jerry Brown signed into law AB2127 which limits, but does not eliminate full contact football practices for middle and high school students.
Beware of Deceptive Home Improvement OffersThe California Contractors State License Board (CSLB) is urging consumers to be aware of home improvement offers by individuals who use unethical business practices to gain entry into their homes
Continuous Improvement Network: August 6th & 20thSierra College CACT provides Value Stream Mapping Training in Sacramento on August 6 & 20 for the Continuous Improvement Network
Alternative Transportation Programs in Placer CountyPlacer County Transportation Planning Agency (PCTPA) is your resource for information about alternative transportation services in Placer County.
Auburn Woman Attacked Inside HomePlacer County sheriff's detectives are looking for a man who attacked a woman at her north Auburn home early this morning.
Western Nationals Softball Tournament in Roseville and LincolnASA Softball is bringing the Western Nationals for the Girls B 10U & 12U divisions to the Placer Valley Area. The event is six days long, taking place from July 28-August 3.
Tahoe Public Projects Garner AttentionTahoe Transportation District has been recognized nationally and by the state of Nevada for its positive impacts, collaborative initiatives, environmental enhancement, and service to the community's
Rocklin National Night Out Events August 5thEach community member is invited to join their neighborhood watch group and the Rocklin Police Department for National Night Out on Tuesday, August 5, 2014.
Recovery Plan for California Salmon and SteelheadNOAA Fisheries and the California Department of Fish and Wildlife (CDFW) jointly released two plans to restore populations of salmon and steelhead in California's Central Valley